The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)

EBioMedicine

Volumn 12, Issue , 2016, Pages 189-195

  Janjua, Naveed Z ^a,b   Kuo, Margot ^a   Yu, Amanda ^a   Alvarez, Maria ^a   Wong, Stanley ^a   Cook, Darrel ^a   Wong, Jason ^a,b   Grebely, Jason ^c   Butt, Zahid A ^a,b   Samji, Hasina ^a,b   Ramji, Alnoor ^b   Tyndall, Mark ^a,b   Krajden, Mel ^a,b  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cascade of care; Engagement with care; Hepatitis C; Linkage with care; Prevalence; Testing; Treatment

Indexed keywords

PEGINTERFERON; RIBAVIRIN; ANTIVIRUS AGENT; VIRUS RNA;

ARTICLE; CANADA; FEMALE; HEALTH CARE; HEPATITIS C; HUMAN; MALE; MIXED INFECTION; PARASITE PREVALENCE; PATIENT MONITORING; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS; VIREMIA; ADULT; AGED; BRITISH COLUMBIA; COHORT ANALYSIS; GENETICS; GENOTYPE; HEALTH CARE DELIVERY; HEALTH SURVEY; HEPACIVIRUS; MIDDLE AGED; MOLECULAR TYPING; PREVALENCE; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; BRITISH COLUMBIA; COHORT STUDIES; COINFECTION; DELIVERY OF HEALTH CARE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; POPULATION SURVEILLANCE; PREVALENCE; RNA, VIRAL; TREATMENT OUTCOME;

EID: 84992571527     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.08.035     Document Type: Article

References (37)

1. Aspinall, E.J., Corson, S., Doyle, J.S., et al. Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin. Infect. Dis. 57:Suppl 2 (2013), S80–S89.
2. Aspinall, E.J., Hutchinson, S.J., Janjua, N.Z., et al. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment. J. Hepatol. 62:2 (2015), 269–277.
3. BC Vital Statistics Agency, Vital Statistics Deaths. BC Vital Statistics Agency. Data Extract. BC Vital Statistics Agency (2014), 2014.
4. British Columbia Ministry of Health, Client Roster (Client Registry System/Enterprise Master Patient Index). British Columbia Ministry of Health. Data Extract. MOH (2013), 2014 http://www.health.gov.bc.ca/data/.
5. British Columbia Ministry of Health, Discharge Abstract Database (Hospital Separations). British Columbia Ministry of Health. Data Extract. MOH (2013), 2014 http://www.health.gov.bc.ca/data/.
6. British Columbia Ministry of Health, Medical Services Plan (MSP) Payment Information File. British Columbia Ministry of Health. Data Extract. MOH (2013), 2014 http://www.health.gov.bc.ca/data/.
7. British Columbia Ministry of Health, PharmaCare. British Columbia Ministry of Health. Data Extract. MOH (2013), 2014 http://www.health.gov.bc.ca/data/.
8. British Columbia Ministry of Health, PharmaNet. British Columbia Ministry of Health. Data Extract. MOH (2013), 2014 http://www.health.gov.bc.ca/data/.
9. Butt, G., McGuinness, L., Buller-Taylor, T., Mitchell, S., Reasons for nonattendance across the hepatitis C disease course. ISRN Nurs, 2013, 2013, 579529.
10. Cachay, E.R., Hill, L., Wyles, D., et al. The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care. PLoS One, 9(7), 2014, e102883.
11. Consolacion, T.B., Yu, A., Janjua, N.Z., et al. Impact of STOP HIV/AIDS Program on HIV, Hepatitis C and Syphilis Testing Volumes in British Columbia. IAS 2015. Vancouver. 2015.
12. Grebely, J., Oser, M., Taylor, L.E., Dore, G.J., Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels. The Journal of infectious diseases 207:Suppl 1 (2013), S19–S25.
13. Guirgis, M., Yan, K., Bu, Y.M., Zekry, A., General practitioners’ knowledge and management of viral hepatitis in the migrant population. Intern. Med. J. 42:5 (2012), 497–504.
14. Hajarizadeh, B., Grebely, J., McManus, H., et al. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment. J. Gastroenterol. Hepatol., 2016.
15. Janjua, N.Z., Kuo, M., Chong, M., et al. Assessing hepatitis C burden and treatment effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): design and characteristics of linked and unlinked participants. PLoS One, 11(3), 2016, e0150176.
16. Janjua, N.Z., Yu, A., Kuo, M., Alvarez, M., Krajden, M., Hepatitis C epidemiology in British Columbia to inform screening and treatment response. 2015 CAG CDDW/CASL Meeting, 2015, 2015, A235 Banff, AB.
17. Janjua, N.Z., Yu, A., Kuo, M., et al. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC hepatitis testers cohort. BMC Infect. Dis., 16, 2016, 334.
18. Jonas, M.C., Rodriguez, C.V., Redd, J., Sloane, D.A., Winston, B.J., Loftus, B.C., Streamlining screening to treatment: the hepatitis C cascade of care at Kaiser Permanente Mid-Atlantic States. Clin. Infect. Dis. 62:10 (2016), 1290–1296.
19. Kramer, J.R., Davila, J.A., Miller, E.D., Richardson, P., Giordano, T.P., El-Serag, H.B., The validity of viral hepatitis and chronic liver disease diagnoses in veterans affairs administrative databases. Aliment. Pharmacol. Ther. 27:3 (2008), 274–282.
20. Kuo, M., Janjua, N.Z., Burchell, A.N., Buxton, J.A., Krajden, M., Gilbert, M., Decreasing Hepatitis C incidence among a population with repeated tests: British Columbia, Canada, 1993–2011. Am. J. Public Health 105:8 (2015), 1604–1610.
21. Lazarus, J.V., Sperle, I., Maticic, M., Wiessing, L., A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region. BMC Infect. Dis., 14(Suppl 6), 2014, S16.
22. Lo Re, V. 3rd, Lim, J.K., Goetz, M.B., et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol. Drug Saf. 20:7 (2011), 689–699.
23. Maier, M.M., Ross, D.B., Chartier, M., Belperio, P.S., Backus, L.I., Cascade of care for hepatitis C virus infection within the US Veterans Health Administration. Am. J. Public Health 106:2 (2016), 353–358.
24. McDonald, S.A., Hutchinson, S.J., Bird, S.M., et al. Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study. Eur. J. Gastroenterol. Hepatol. 22:1 (2010), 49–57.
25. Nehra, M.S., Ma, Y., Clark, C., Amarasingham, R., Rockey, D.C., Singal, A.G., Use of administrative claims data for identifying patients with cirrhosis. J. Clin. Gastroenterol. 47:5 (2013), e50–e54.
26. Nosyk, B., Montaner, J.S., Colley, G., et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect. Dis. 14:1 (2014), 40–49.
27. Pampalon, R., Gamache, P., Hamel, D., A deprivation index for health planning in Canada. Chronic Dis. Can., 29(4), 2009.
28. Simmons, B., Saleem, J., Heath, K., Cooke, G.S., Hill, A., Long-term treatment outcomes of patients infected with Hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response. Clin. Infect. Dis. 61:5 (2015), 730–740.
29. Singal, A.G., Volk, M.L., Jensen, D., Di Bisceglie, A.M., Schoenfeld, P.S., A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin. Gastroenterol. Hepatol. 8:3 (2010), 280–288.
30. Smith, M.A., Lim, A., Profile of paritaprevir/ritonavir/ombitasvir plus dasabuvir in the treatment of chronic hepatitis C virus genotype 1 infection. Drug Des. Devel. Ther. 9 (2015), 6083–6094.
31. Smith, M.A., Chan, J., Mohammad, R.A., Ledipasvir-sofosbuvir: interferon −/ribavirin-free regimen for chronic hepatitis C virus infection. Ann. Pharmacother. 49:3 (2015), 343–350.
32. Spradling, P.R., Tong, X., Rupp, L.B., et al. Trends in HCV RNA testing among HCV antibody-positive persons in care, 2003-2010. Clin. Infect. Dis. 59:7 (2014), 976–981.
33. Stats, B.C., Population Estimates. http://www.bcstats.gov.bc.ca/StatisticsBySubject/Demography/PopulationEstimates.aspx2015, 2012.
34. Trubnikov, M., Yan, P., Archibald, C., Estimated prevalence of hepatitis C virus infection in Canada, 2011. Can. Commun. Dis. Rep. 40:19 (2014), 429–442.
35. Viner, K., Kuncio, D., Newbern, E.C., Johnson, C.C., The continuum of hepatitis C testing and care. Hepatology 61:3 (2015), 783–789.
36. Wade, A.J., Macdonald, D.M., Doyle, J.S., et al. The cascade of care for an Australian community-based hepatitis C treatment service. PLoS One, 10(11), 2015, e0142770.
37. World Health Organization, Global health sector strategy on viral hepatitis 2016-2021. Available from: Towards ending viral hepatitis, 2016 http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua=1.